H
Hong Liu
Researcher at Shandong University
Publications - 2349
Citations - 79103
Hong Liu is an academic researcher from Shandong University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 100, co-authored 1905 publications receiving 57561 citations. Previous affiliations of Hong Liu include Shanghai University & Guangzhou University.
Papers
More filters
Journal ArticleDOI
High efficiency perovskite solar cells with tailorable surface wettability by surfactant
TL;DR: In this paper, an ultrathin sodium dodecyl benzene sulfonate (SDBS) film is introduced between the perovskite absorber and the NiOx hole transport layer to reduce interfacial and extraction losses.
Journal ArticleDOI
Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling.
Mingfang Zheng,Mingyue Zheng,Deju Ye,Yangmei Deng,Shuifeng Qiu,Xiaomin Luo,Kaixian Chen,Hong Liu,Hualiang Jiang,Hualiang Jiang +9 more
TL;DR: A series of novel indole derivatives was designed, synthesized and evaluated by cell-based assays for their inhibitory activities against 5-LOX in rat peritoneal leukocytes, showing excellent in vitro activities and may possess potential for the treatment of LT-related diseases.
Journal ArticleDOI
Nitrogen-doped carbon encapsulated hollow ZnSe/CoSe2 nanospheres as high performance anodes for lithium-ion batteries.
TL;DR: As an advanced anode, ZnSe/CoSe2@N-C composite shows remarkable cycling stability and exceptional rate capability in the field of energy storage technologies.
Journal ArticleDOI
In situ alternative switching between Ti4+ and Ti3+ driven by H2O2 in TiO2 nanostructures: mechanism of pseudo-Fenton reaction
TL;DR: In this article, it was shown that Ti4+ in TiO2 nanostructures can be reduced in situ to Ti3+ in the presence of H2O2 to generate hydroxyl radicals for the oxidation of organic pollutants.
Journal ArticleDOI
One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation.
Jian Li,Jing Chen,Li Zhang,Feng Wang,Chunshan Gui,Yu Qin,Qiang Xu,Hong Liu,Fajun Nan,Jingkang Shen,Donglu Bai,Kaixian Chen,Xu Shen,Xu Shen,Hualiang Jiang,Hualiang Jiang +15 more
TL;DR: A novel quinoxaline derivative, 2,3-di(furan-2-yl)-6-(3-N,N-diethylcarbamoyl-piperidino)carbonylamino quin oxaline (DC838, 3), which was confirmed to be a potent inhibitor against human CypA, and elucidated the specific DC838 binding to CypA at the atomic level.